General Administration of Sport of China

LRQA Chairman Martin Blackburn Spearheads Sustainable Growth and Partnerships during UAE Visit

Retrieved on: 
Friday, July 7, 2023

DUBAI, UAE, July 7, 2023 /PRNewswire/ -- LRQA's Chairman Martin Blackburn visited the UAE, heading a delegation of LRQA colleagues that held meetings with various clients, local partners, as well as internal work meetings with the Assessments and Inspection teams.

Key Points: 
  • DUBAI, UAE, July 7, 2023 /PRNewswire/ -- LRQA's Chairman Martin Blackburn visited the UAE, heading a delegation of LRQA colleagues that held meetings with various clients, local partners, as well as internal work meetings with the Assessments and Inspection teams.
  • Martin accompanied by Luis Cunha, Regional Director and Ayman Ktaily, Country Lead attended a ceremony hosted by H.E Rashed Lahej Al Mansoori, Director General, General Administration of Customs.
  • 24 certifications from LRQA were on display that Abu Dhabi Customs had achieved for their management systems.
  • He is involved in multiple capacities with several UAE companies, and we look forward to strengthening this relationship.

CGTN: China confident on 5% growth target, continues to drive global economy

Retrieved on: 
Tuesday, June 27, 2023

According to the World Bank, China's economy is expected to grow by 5.6 percent in 2023, an increase of 1.3 percent from the January projection.

Key Points: 
  • According to the World Bank, China's economy is expected to grow by 5.6 percent in 2023, an increase of 1.3 percent from the January projection.
  • Highlighting that China's economy is deeply integrated with the world economy, Li said China develops itself in globalization and becomes the firmest force of maintaining globalization.
  • As Allianz Group's Chairman and CEO Oliver Bate said when attending China Development Forum in March, the international community needs China more than ever.
  • China stands ready to unswervingly uphold the market economy and support free trade to steer the world economy toward a more inclusive, resilient and sustainable future, the premier said.

CGTN: China confident on 5% growth target, continues to drive global economy

Retrieved on: 
Tuesday, June 27, 2023

According to the World Bank, China's economy is expected to grow by 5.6 percent in 2023, an increase of 1.3 percent from the January projection.

Key Points: 
  • According to the World Bank, China's economy is expected to grow by 5.6 percent in 2023, an increase of 1.3 percent from the January projection.
  • Highlighting that China's economy is deeply integrated with the world economy, Li said China develops itself in globalization and becomes the firmest force of maintaining globalization.
  • As Allianz Group's Chairman and CEO Oliver Bate said when attending China Development Forum in March, the international community needs China more than ever.
  • China stands ready to unswervingly uphold the market economy and support free trade to steer the world economy toward a more inclusive, resilient and sustainable future, the premier said.

Global Times: Sprawling transport network prompts Central Asia from 'land-locked' to 'land-linked'

Retrieved on: 
Monday, May 22, 2023

The Chang'an China-Europe freight train service, a vital transport link between Xi'an and European cities, has started operation in 2013, when the BRI was proposed.

Key Points: 
  • The Chang'an China-Europe freight train service, a vital transport link between Xi'an and European cities, has started operation in 2013, when the BRI was proposed.
  • Meanwhile, as trade grows, goods delivered by the sprawling transport network are also expanding from raw materials and rubber products, clothing to food.
  • Speaking with industry insiders, the Global Times reporters have learned how the transport network facilities have promoted the development of the trade and investment in the region.
  • The five Central Asian countries play a crucial role in connecting Europe and Asia, with nearly 80 percent of China-Europe freight trains passing through Central Asia.

CGTN: How to open up a new era of China, Central Asia cooperation

Retrieved on: 
Friday, May 19, 2023

The presidents of the five Central Asian countries are all in Xi'an, northwest China's Shaanxi Province, to attend the China-Central Asia Summit, which is scheduled for Thursday and Friday.

Key Points: 
  • The presidents of the five Central Asian countries are all in Xi'an, northwest China's Shaanxi Province, to attend the China-Central Asia Summit, which is scheduled for Thursday and Friday.
  • In the past decade, Xi visited Central Asia seven times and also hosted multiple Central Asian leaders in China.
  • Guided by head-of-state diplomacy, the friendship and political mutual trust between China and the five Central Asian countries have been constantly deepened.
  • During his meeting with Tajik President Emomali Rahmon, Xi said he is convinced that, with the concerted efforts of all parties, the China-Central Asia Summit will open a new chapter for China-Central Asia cooperation.

CGTN: How to open up a new era of China, Central Asia cooperation

Retrieved on: 
Friday, May 19, 2023

The presidents of the five Central Asian countries are all in Xi'an, northwest China's Shaanxi Province, to attend the China-Central Asia Summit, which is scheduled for Thursday and Friday.

Key Points: 
  • The presidents of the five Central Asian countries are all in Xi'an, northwest China's Shaanxi Province, to attend the China-Central Asia Summit, which is scheduled for Thursday and Friday.
  • In the past decade, Xi visited Central Asia seven times and also hosted multiple Central Asian leaders in China.
  • Guided by head-of-state diplomacy, the friendship and political mutual trust between China and the five Central Asian countries have been constantly deepened.
  • During his meeting with Tajik President Emomali Rahmon, Xi said he is convinced that, with the concerted efforts of all parties, the China-Central Asia Summit will open a new chapter for China-Central Asia cooperation.

Verve Therapeutics Announces Pipeline Progress and Expansion and Reports First Quarter 2023 Financial Results

Retrieved on: 
Monday, May 15, 2023

BOSTON, May 15, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today reported pipeline progress and financial results for the first quarter of 2023.

Key Points: 
  • “The focus at Verve is to develop life-changing medicines for people with cardiovascular disease,” said Sekar Kathiresan, M.D., co-founder and chief executive officer of Verve.
  • When we started, we took what was a new base editing technology and an in-licensed lipid nanoparticle (LNP) and created VERVE-101.
  • Research & Development (R&D) Expenses: R&D expenses were $47.1 million for the first quarter of 2023, compared to $24.5 million for the first quarter of 2022.
  • General & Administrative (G&A) Expenses: G&A expenses were $12.6 million for the first quarter of 2023, compared to $7.4 million for the first quarter of 2022.

vTv Therapeutics Announces 2023 First Quarter Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, May 11, 2023

HIGH POINT, N.C., May 11, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of an adjunctive therapy to insulin for the treatment of type 1 diabetes ("T1D"), today reported financial results for the first quarter ended March 31, 2023, and provided an update on recent corporate developments.

Key Points: 
  • HIGH POINT, N.C., May 11, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of an adjunctive therapy to insulin for the treatment of type 1 diabetes ("T1D"), today reported financial results for the first quarter ended March 31, 2023, and provided an update on recent corporate developments.
  • As of March 31, 2023, the Company’s cash and cash equivalents totaled approximately $18.8 million.
  • Net Loss: Net loss attributable to vTv shareholders for the three months ended March 31, 2023, was $4.5 million or $0.06 per basic share.
  • Net loss attributable to vTv shareholders for the comparable period a year ago was $7.0 million or $0.10 per basic share.

Allied Gaming & Entertainment Announces First Quarter 2023 Financial Results

Retrieved on: 
Thursday, May 11, 2023

Allied Gaming & Entertainment, Inc. (NASDAQ: AGAE) (the “Company” or “AGAE”), a global experiential entertainment company, today announced financial results for the first quarter ended March 31, 2023.

Key Points: 
  • Allied Gaming & Entertainment, Inc. (NASDAQ: AGAE) (the “Company” or “AGAE”), a global experiential entertainment company, today announced financial results for the first quarter ended March 31, 2023.
  • Allied Esports produced 82 events in the first quarter of 2023, with 42 proprietary events and 40 third-party events.
  • The Company will host a conference call today at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its first quarter 2023 financial results.
  • Additionally, financial information presented on the call will be available on Allied Gaming & Entertainment’s Investor Relations site.

TFF Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results

Retrieved on: 
Thursday, May 11, 2023

“The first quarter of 2023 proved to be highly productive for our company,” said Dr. Harlan Weisman, Chief Executive Officer of TFF Pharmaceuticals.

Key Points: 
  • “The first quarter of 2023 proved to be highly productive for our company,” said Dr. Harlan Weisman, Chief Executive Officer of TFF Pharmaceuticals.
  • In February 2023, the Company provided updated guidance for the TFF VORI and TFF TAC clinical programs on its Corporate Strategy Conference Call .
  • For the quarter ended March 31, 2023, compared to quarter ended March 31, 2022
    Cash Position: as of March 31, 2023, TFF Pharmaceuticals reported cash and cash equivalents of $12.2 million.
  • Net Loss: TFF Pharmaceuticals reported a net loss for the first quarter of 2023 of $7.1 million, compared to a net loss of $8.4 million for the comparable period in 2022.